|
Name |
Acetoxydehydroaustin
|
Molecular Formula | C29H32O11 | |
IUPAC Name* |
[(2R,3S)-8-acetyloxy-2,2',2',9,13-pentamethyl-6,16-dimethylidene-6',11,15-trioxospiro[10,14,17-trioxapentacyclo[7.6.1.17,12.01,12.02,7]heptadecane-5,3'-pyran]-3-yl] acetate
|
|
SMILES |
CC1C23C(=O)OC4(C(C5(O2)C(=C)C6(C[C@@H]([C@]5(C3(C4=C)C(=O)O1)C)OC(=O)C)C=CC(=O)OC6(C)C)OC(=O)C)C
|
|
InChI |
InChI=1S/C29H32O11/c1-13-24(8)20(37-17(5)31)28-14(2)26(11-10-19(32)38-23(26,6)7)12-18(36-16(4)30)25(28,9)27(13)21(33)35-15(3)29(27,40-28)22(34)39-24/h10-11,15,18,20H,1-2,12H2,3-9H3/t15?,18-,20?,24?,25-,26?,27?,28?,29?/m0/s1
|
|
InChIKey |
YQYVCCPRXKJSEE-GAPBAJQCSA-N
|
|
Synonyms |
Acetoxydehydroaustin; 154563-84-5
|
|
CAS | NA | |
PubChem CID | 101660521 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 556.6 | ALogp: | 1.2 |
HBD: | 0 | HBA: | 11 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 141.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 40 | QED Weighted: | 0.282 |
Caco-2 Permeability: | -5.257 | MDCK Permeability: | 0.00004700 |
Pgp-inhibitor: | 0.991 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.734 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 0.981 |
Blood-Brain-Barrier Penetration (BBB): | 0.126 | Plasma Protein Binding (PPB): | 60.12% |
Volume Distribution (VD): | 1.508 | Fu: | 40.05% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.897 |
CYP2C19-inhibitor: | 0.027 | CYP2C19-substrate: | 0.732 |
CYP2C9-inhibitor: | 0.03 | CYP2C9-substrate: | 0.014 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.033 |
CYP3A4-inhibitor: | 0.487 | CYP3A4-substrate: | 0.925 |
Clearance (CL): | 1.54 | Half-life (T1/2): | 0.019 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.761 |
Drug-inuced Liver Injury (DILI): | 0.967 | AMES Toxicity: | 0.951 |
Rat Oral Acute Toxicity: | 0.957 | Maximum Recommended Daily Dose: | 0.211 |
Skin Sensitization: | 0.027 | Carcinogencity: | 0.973 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.4 |
Respiratory Toxicity: | 0.859 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003159 | 1.000 | D03ZZK | 0.242 | ||||
ENC005316 | 1.000 | D0H2MO | 0.241 | ||||
ENC006041 | 0.880 | D0G7KJ | 0.236 | ||||
ENC005315 | 0.821 | D0KR9U | 0.233 | ||||
ENC003776 | 0.767 | D0OL7F | 0.222 | ||||
ENC004311 | 0.754 | D09SIK | 0.214 | ||||
ENC003309 | 0.741 | D08BDT | 0.213 | ||||
ENC006040 | 0.714 | D09WYX | 0.213 | ||||
ENC004812 | 0.646 | D06XHC | 0.205 | ||||
ENC004811 | 0.646 | D01ZOG | 0.201 |